Anti-GPC3-CAR T Cells Suppress the Growth of Tumor Cells in Patient-Derived Xenografts of Hepatocellular Carcinoma
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-GPC3-CAR T Cells Suppress the Growth of Tumor Cells in Patient-Derived Xenografts of Hepatocellular Carcinoma
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 7, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-01-11
DOI
10.3389/fimmu.2016.00690
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Redirecting T Cells to Glypican-3 with 4-1BB Zeta Chimeric Antigen Receptors Results in Th1 Polarization and Potent Antitumor Activity
- (2017) Wenpeng Li et al. HUMAN GENE THERAPY
- Heterogeneity of CD34 and CD38 expression in acute B lymphoblastic leukemia cells is reversible and not hierarchically organized
- (2016) Zhiwu Jiang et al. Journal of Hematology & Oncology
- Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma
- (2016) Aparna Jayachandran et al. Journal of Hematology & Oncology
- Novel patient-derived xenograft and cell line models for therapeutic testing of pediatric liver cancer
- (2016) Beatrice Bissig-Choisat et al. JOURNAL OF HEPATOLOGY
- T Cells Engineered to Express a T-Cell Receptor Specific for Glypican-3 to Recognize and Kill Hepatoma Cells In Vitro and in Mice
- (2015) Christina Dargel et al. GASTROENTEROLOGY
- Loss of Angiopoietin-like 7 diminishes the regeneration capacity of hematopoietic stem and progenitor cells
- (2015) Yiren Xiao et al. Journal of Hematology & Oncology
- Quantitative evaluation of the immunodeficiency of a mouse strain by tumor engraftments
- (2015) Wei Ye et al. Journal of Hematology & Oncology
- 4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors
- (2015) Adrienne H Long et al. NATURE MEDICINE
- CD4+CD25+CD127low Regulatory T Cells Play Predominant Anti-Tumor Suppressive Role in Hepatitis B Virus-Associated Hepatocellular Carcinoma
- (2015) Shreya Sharma et al. Frontiers in Immunology
- Development of T Cells Redirected to Glypican-3 for the Treatment of Hepatocellular Carcinoma
- (2014) H. Gao et al. CLINICAL CANCER RESEARCH
- Multifactorial T-cell Hypofunction That Is Reversible Can Limit the Efficacy of Chimeric Antigen Receptor-Transduced Human T cells in Solid Tumors
- (2014) E. K. Moon et al. CLINICAL CANCER RESEARCH
- Establishment and Characterization of 7 Novel Hepatocellular Carcinoma Cell Lines from Patient-Derived Tumor Xenografts
- (2014) Hong Xin et al. PLoS One
- Anti-PD-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors By Gene-Modified T Cells
- (2013) L. B. John et al. CLINICAL CANCER RESEARCH
- A Hepatocellular Carcinoma 5-Gene Score Associated With Survival of Patients After Liver Resection
- (2013) Jean–Charles Nault et al. GASTROENTEROLOGY
- Chimeric antigen receptor-engineered T cells for cancer immunotherapy: progress and challenges
- (2013) Ethan Q Han et al. Journal of Hematology & Oncology
- Hepatocellular Carcinoma
- (2013) Andrew J. Page et al. Surgical Oncology Clinics of North America
- Patient-derived tumour xenografts as models for oncology drug development
- (2012) John J. Tentler et al. Nature Reviews Clinical Oncology
- Patient-derived human tumour tissue xenografts in immunodeficient mice: a systematic review
- (2010) Ketao Jin et al. Clinical & Translational Oncology
- Tumour-experienced T cells promote NK cell activity through trogocytosis of NKG2D and NKp46 ligands
- (2009) Carolina I Domaica et al. EMBO REPORTS
- PD-1 and Its Ligands in Tolerance and Immunity
- (2008) Mary E. Keir et al. Annual Review of Immunology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now